Commonwealth Equity Services’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $588K | Sell |
7,829
-3,977
| -34% | -$314K | ﹤0.01% | 3078 |
|
|
2025
Q4 | $934K | Sell |
11,806
-1,543
| -12% | -$116K | ﹤0.01% | 2637 |
|
|
2025
Q3 | $873K | Sell |
13,349
-593
| -4% | -$29K | ﹤0.01% | 2708 |
|
|
2025
Q2 | $551K | Sell |
13,942
-2,456
| -15% | -$80.4K | ﹤0.01% | 3064 |
|
|
2025
Q1 | $495K | Sell |
16,398
-5,428
| -25% | -$178K | ﹤0.01% | 3028 |
|
|
2024
Q4 | $763K | Buy |
21,826
+373
| +2% | +$13.9K | ﹤0.01% | 2614 |
|
|
2024
Q3 | $859K | Sell |
21,453
-1,216
| -5% | -$56.6K | ﹤0.01% | 2467 |
|
|
2024
Q2 | $1.08M | Buy |
22,669
+695
| +3% | +$28.5K | ﹤0.01% | 2223 |
|
|
2024
Q1 | $953K | Buy |
21,974
+512
| +2% | +$24.4K | ﹤0.01% | 2282 |
|
|
2023
Q4 | $1.09M | Sell |
21,462
-8
| -0% | -$383 | ﹤0.01% | 2113 |
|
|
2023
Q3 | $974K | Buy |
21,470
+897
| +4% | +$37K | ﹤0.01% | 2090 |
|
|
2023
Q2 | $844K | Sell |
20,573
-65
| -0.3% | -$2.5K | ﹤0.01% | 2226 |
|
|
2023
Q1 | $737 | Sell |
20,638
-66
| -0.3% | -$2.48K | ﹤0.01% | 2250 |
|
|
2022
Q4 | $781K | Sell |
20,704
-543
| -3% | -$22.8K | ﹤0.01% | 2126 |
|
|
2022
Q3 | $939K | Sell |
21,247
-2,517
| -11% | -$106K | ﹤0.01% | 1944 |
|
|
2022
Q2 | $879K | Sell |
23,764
-2,229
| -9% | -$84.1K | ﹤0.01% | 1996 |
|
|
2022
Q1 | $962K | Sell |
25,993
-2,773
| -10% | -$90.8K | ﹤0.01% | 2029 |
|
|
2021
Q4 | $875K | Sell |
28,766
-9,352
| -25% | -$294K | ﹤0.01% | 2090 |
|
|
2021
Q3 | $1.28M | Buy |
38,118
+12,388
| +48% | +$467K | ﹤0.01% | 1741 |
|
|
2021
Q2 | $1.03M | Buy |
25,730
+7,594
| +42% | +$297K | ﹤0.01% | 1890 |
|
|
2021
Q1 | $815K | Sell |
18,136
-870
| -5% | -$48.5K | ﹤0.01% | 1948 |
|
|
2020
Q4 | $1.07M | Sell |
19,006
-438
| -2% | -$21.8K | ﹤0.01% | 1608 |
|
|
2020
Q3 | $922K | Sell |
19,444
-648
| -3% | -$36K | ﹤0.01% | 1545 |
|
|
2020
Q2 | $1.18M | Buy |
20,092
+571
| +3% | +$31.8K | ﹤0.01% | 1319 |
|
|
2020
Q1 | $922K | Buy |
19,521
+710
| +4% | +$39.6K | ﹤0.01% | 1308 |
|
|
2019
Q4 | $1.14M | Sell |
18,811
-791
| -4% | -$47.1K | ﹤0.01% | 1345 |
|
|
2019
Q3 | $1.17M | Buy |
19,602
+42
| +0.2% | +$2.74K | 0.01% | 1267 |
|
|
2019
Q2 | $1.26M | Buy |
19,560
+374
| +2% | +$26.4K | 0.01% | 1208 |
|
|
2019
Q1 | $1.56M | Buy |
19,186
+259
| +1% | +$16.7K | 0.01% | 1044 |
|
|
2018
Q4 | $1.02M | Buy |
18,927
+792
| +4% | +$40.4K | 0.01% | 1189 |
|
|
2018
Q3 | $935K | Sell |
18,135
-660
| -4% | -$31K | ﹤0.01% | 1344 |
|
|
2018
Q2 | $783K | Sell |
18,795
-351
| -2% | -$15.6K | ﹤0.01% | 1439 |
|
|
2018
Q1 | $843K | Buy |
19,146
+206
| +1% | +$10.5K | ﹤0.01% | 1355 |
|
|
2017
Q4 | $953K | Buy |
18,940
+740
| +4% | +$40.6K | 0.01% | 1246 |
|
|
2017
Q3 | $923K | Sell |
18,200
-676
| -4% | -$35.4K | 0.01% | 1230 |
|
|
2017
Q2 | $960K | Buy |
18,876
+573
| +3% | +$26.7K | 0.01% | 1169 |
|
|
2017
Q1 | $736K | Buy |
18,303
+608
| +3% | +$27.3K | ﹤0.01% | 1272 |
|
|
2016
Q4 | $846K | Sell |
17,695
-1,316
| -7% | -$52.1K | 0.01% | 1115 |
|
|
2016
Q3 | $697K | Buy |
19,011
+2,594
| +16% | +$81.2K | 0.01% | 1191 |
|
|
2016
Q2 | $382K | Sell |
16,417
-16,129
| -50% | -$520K | ﹤0.01% | 1519 |
|
|
2016
Q1 | $1.32M | Buy |
32,546
+1,679
| +5% | +$68.2K | 0.01% | 827 |
|
|
2015
Q4 | $1.91M | Buy |
30,867
+908
| +3% | +$49K | 0.02% | 639 |
|
|
2015
Q3 | $1.21M | Buy |
29,959
+396
| +1% | +$20.5K | 0.01% | 808 |
|
|
2015
Q2 | $1.7M | Sell |
29,563
-3,904
| -12% | -$248K | 0.02% | 689 |
|
|
2015
Q1 | $2.13M | Buy |
33,467
+6,346
| +23% | +$431K | 0.02% | 578 |
|
|
2014
Q4 | $1.67M | Buy |
27,121
+16,645
| +159% | +$821K | 0.02% | 645 |
|
|
2014
Q3 | $407K | Buy |
10,476
+1,672
| +19% | +$59.3K | ﹤0.01% | 1370 |
|
|
2014
Q2 | $303K | Buy |
8,804
+3,776
| +75% | +$119K | ﹤0.01% | 1541 |
|
|
2014
Q1 | $217K | Buy |
+5,028
| New | +$244K | ﹤0.01% | 1700 |
|
|
2013
Q4 | – | Sell |
-5,350
| Closed | -$201K | – | 1954 |
|
|
2013
Q3 | $201K | Buy |
+5,350
| New | +$160K | ﹤0.01% | 1629 |
|
Other funds holding IONS
VPM
VCM
Commonwealth Equity Services's IONS Position: Q1 2026 in Review
Commonwealth Equity Services reduced its Ionis Pharmaceuticals (IONS) stake by 34% in Q1 2026, selling an estimated $314K and leaving 7,829 shares worth $588K. The position accounts for ﹤0.01% of the portfolio, ranked #3078.
Commonwealth Equity Services first reported a position in IONS in Q3 2013 and has held it in 50 quarters since. The position peaked at $2.13M in Q1 2015. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Commonwealth Equity Services held 7,829 shares of Ionis Pharmaceuticals worth $588K as of Q1 2026.
- Commonwealth Equity Services sold 3,977 Ionis Pharmaceuticals shares in Q1 2026, an estimated $314K.
- Ionis Pharmaceuticals made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #3078 holding.
- Commonwealth Equity Services first reported a position in Ionis Pharmaceuticals in Q3 2013 and has held it in 50 quarters since.
- Commonwealth Equity Services's Ionis Pharmaceuticals position peaked at $2.13M in Q1 2015.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.